Lobbying Filing Details

Total Spending

$830,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
3f255330-eac7-415d-910d-4cc88a1c4ab3
Type:
Q1 - 1st Quarter - Report
Period:
2023 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 21, 2023 at 1:12 AM
Income:
$0
Expenses:
$830,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: G. Joel Baise, Director, Government Relations
Registrant
WALGREEN COMPANY

Retail Pharmacy

WASHINGTON, District of Columbia
Client
WALGREEN COMPANY
District of Columbia, United States of America
Lobbying Activities (1)
Activity 1
Pharmacy

H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.

Lobbyists (2)
  • KATIE L SMITH
  • MRS. MADELINE KAY HODGE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.